Financial Daily from THE HINDU group of publications
Friday, Aug 26, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Awards & Honours


Ranbaxy US arm gets award

Our Bureau

NEW DELHI: Ranbaxy Laboratories Ltd's wholly owned subsidiary, Ranbaxy Pharmaceuticals Inc (RPI), USA, has received the Supplier Quality Award from Cardinal Health. Cardinal Health is the second largest wholesaler in the US, which supports over 31,000 pharmacies throughout the country. Earlier in June this year, RPI had also received the prestigious Supplier Award from Wal-Mart, the largest chain store in the US, for outstanding performance in the first quarter of 2005.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Glenmark's asthma drug gets nod for further trials


Bannari Amman Spinning to tap market for expansion
Amartex to go in for IPO to fund retail expansion
Jagsonpal Pharma to pay 20%
Dr Reddy's sunscreen gel
Morepen files 52 DMF
Scribe of Priyamvada Birla's will moves SC
Haldia Petro: CLB reserves order on TCG plea, clubs it with main petition
IOC to raise $670 m loan to refinance debt, import crude
Ranbaxy US arm gets award
IOC-OIL combine eyes tie-up with Statoil — Other Indian companies to join
L&T to acquire Datar Switchgear, to assume Rs 24-cr debt
We are not hungry for iron ore, says POSCO
CAG highlights deficiencies in ordnance factories' functioning
Coal India, OIL plan joint venture for liquefaction plant
Grandix Pharma ties up with Italian co
Crest Animation's US arm, Lions Gate to co-produce 3 films
Pantaloon Retail okays 1:5 rights issue
Gangotri Textiles board okays stock split, 1:1 bonus issue
Jharkhand project: `Tata Steel's worry is on equipment supplies, project management'
Amara Raja sales target


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line